We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+12.86%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$158M
AUM Growth
-$7.14M
Cap. Flow
-$21.7M
Cap. Flow %
-13.81%
Top 10 Hldgs %
5.64%
Holding
474
New
40
Increased
153
Reduced
231
Closed
49

Top Buys

Rank Stock Value
1
EXPE icon
Expedia Group
EXPE
+$752K
2
IT icon
Gartner
IT
+$681K
3
TT icon
Trane Technologies
TT
+$681K
4
ETN icon
Eaton
ETN
+$660K
5
PLD icon
Prologis
PLD
+$658K

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$854K
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$778K
3
IEX icon
IDEX
IEX
+$731K
4
TSLA icon
Tesla
TSLA
+$719K
5
YUMC icon
Yum China
YUMC
+$714K

Sector Composition

Rank Sector Weight
1 Healthcare 22.36%
2 Technology 15.51%
3 Financials 14.54%
4 Industrials 9.65%
5 Energy 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
351
Revolution Medicines
RVMD
$38.5B
$102K 0.06%
3,540
-376
-10% -$9.04K
CBAY
352
DELISTED
Cymabay Therapeutics
CBAY
$101K 0.06%
4,278
-7,065
-62% -$126K
MRUS
353
DELISTED
Merus
MRUS
$101K 0.06%
3,662
-69
-2% -$1.61K
AGEN
354
Agenus
AGEN
$276M
$101K 0.06%
6,081
+3,379
+125% +$56K
SNDX icon
355
Syndax Pharmaceuticals
SNDX
$1.7B
$101K 0.06%
4,657
+125
+3% +$1.92K
EXAI
356
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$101K 0.06%
15,692
+1,445
+10% +$8.18K
REPL icon
357
Replimune Group
REPL
$454M
$101K 0.06%
11,931
+7,715
+183% +$89.4K
RCUS icon
358
Arcus Biosciences
RCUS
$3.33B
$100K 0.06%
5,251
+209
+4% +$3.34K
SLNO
359
DELISTED
Soleno Therapeutics
SLNO
$100K 0.06%
+2,490
New +$70.8K
ACLX
360
DELISTED
Arcellx
ACLX
$100K 0.06%
1,805
-800
-31% -$36.1K
PLRX icon
361
Pliant Therapeutics
PLRX
$65M
$100K 0.06%
5,521
+1,455
+36% +$22.1K
IMTX icon
362
Immatics
IMTX
$1.23B
$99.5K 0.06%
9,447
+1,184
+14% +$10.9K
ARWR icon
363
Arrowhead Research
ARWR
$12.1B
$99.2K 0.06%
3,243
+444
+16% +$11.8K
ARDX icon
364
Ardelyx
ARDX
$1.24B
$99K 0.06%
15,962
-8,633
-35% -$38.7K
KRYS icon
365
Krystal Biotech
KRYS
$10.7B
$98.8K 0.06%
796
+30
+4% +$3.33K
PGEN icon
366
Precigen
PGEN
$1.94B
$98.5K 0.06%
73,477
-6,277
-8% -$7.38K
RCKT icon
367
Rocket Pharmaceuticals
RCKT
$343M
$98.1K 0.06%
3,274
-1,082
-25% -$23.9K
AMAM
368
DELISTED
Ambrx Biopharma Inc
AMAM
$97.9K 0.06%
6,878
+85
+1% +$966
IOVA icon
369
Iovance Biotherapeutics
IOVA
$2.04B
$97.6K 0.06%
12,008
+603
+5% +$3.15K
MLTX icon
370
MoonLake Immunotherapeutics
MLTX
$1.56B
$96.9K 0.06%
1,605
-2,082
-56% -$107K
AKRO
371
DELISTED
Akero Therapeutics
AKRO
$96.9K 0.06%
4,148
+2,353
+131% +$46.4K
VERA icon
372
Vera Therapeutics
VERA
$2.33B
$96.7K 0.06%
+6,289
New +$79.9K
MLYS icon
373
Mineralys Therapeutics
MLYS
$2.32B
$96.5K 0.06%
11,222
+5,017
+81% +$39.4K
ABCL icon
374
AbCellera Biologics
ABCL
$1.65B
$96.5K 0.06%
16,894
+3,509
+26% +$16.3K
IDYA icon
375
IDEAYA Biosciences
IDYA
$3.43B
$96.2K 0.06%
2,705
-1,272
-32% -$38K
13 14
15
16 17

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, Virtus ETF Advisers held 474 positions worth $158M, down 4.3% from $165M the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Virtus ETF Advisers withdrew a net $21.7M in Q4 2023, closing 49 positions and reducing 231 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $854K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

Against the trend, Virtus ETF Advisers opened a new position in Expedia Group worth $932K.

  • Virtus ETF Advisers's largest Q4 2023 buy was Expedia Group: 6,139 shares worth $932K.
  • Virtus ETF Advisers added most to Pioneer Natural Resource Co. in Q4 2023, an estimated $535K increase.
  • Virtus ETF Advisers's biggest Q4 2023 reduction was VICI Properties, cutting an estimated $659K.
  • Virtus ETF Advisers fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $854K.
  • Virtus ETF Advisers's ten largest holdings make up 5.6% of its $158M portfolio in Q4 2023.
  • Virtus ETF Advisers opened 40 new positions and closed 49 in Q4 2023.
  • Virtus ETF Advisers's portfolio value fell 4.3% quarter-over-quarter to $158M.

Based on Virtus ETF Advisers's 13F filing for Q4 2023, filed 15 Feb 2024.